Abstract:The placenta is responsible for delivering nutrients such as glucose to the fetus to support its growth and development, which is especially important during late gestation when fetal growth is most rapid. The ability of the placenta to efficiently provide nutrients is dependent on its vascular development and the abundance of nutrient transporters at the maternal fetal interface. Maternal choline supplementation (MCS) was shown to improve placental vasculature, but it is still unknown if MCS affects placental transporter abundance and fetal nutrient delivery. To test the hypothesis that MCS beneficially modulates placental glucose supply, pregnant mice were fed a diet containing 1, 2 or 4 times the recommended choline level. The placentas were collected at gestational day (E) 15.5 and 18.5 for evaluating the expression of key glucose transporters and enzymes involved in glycogen metabolism as well as the glycogen concentration. Data were analyzed using a mixed linear model. At E15.5, MCS reduced the membrane protein abundance of Glut1 transporter as well as the mRNA expression of the glycogen synthesizing enzyme Gys1 (p<0.05). The mRNA expression of the glycogen catabolic enzyme Pygm in the female placentas also tended to increase (p=0.08). Consistent with these findings, histological staining of placental glycogen tended to be lower (p=0.08). At E18.5, MCS had no effect on Glut1 transporter expression in either male or female placentas. However, MCS increased the membrane protein abundance of Glut3 transporter and the mRNA abundance of Gys1 in the female placentas (p<0.05). These changes resulted in a 2‐fold increase in glycogen concentration in the female placentas, as shown by histological staining and biochemical measurement (p<0.05). No such changes were seen in the male placentas at this time point. Overall, these data indicate that MCS modulates placental glucose transporter expression and glycogen metabolism in a manner highly dependent on fetal sex. We suggest that these choline‐mediated changes in placental glucose metabolism differentially influence glucose delivery to the fetus, with potential consequences on offspring development and disease risk in later life.Support or Funding InformationUSDA and Egg Nutrition Center

Pregnancy Increases the Use of Choline Derived Methyl Groups for Phosphatidylcholine (PC) Production Through the PEMT Pathway with Subsequent Selective Transfer of PEMT‐PC to the Fetus

Pregnancy Alters Choline Dynamics: Results of a Randomized Trial Using Stable Isotope Methodology in Pregnant and Nonpregnant Women.

Choline Intake Influences Phosphatidylcholine DHA Enrichment in Nonpregnant Women but Not in Pregnant Women in the Third Trimester.

Pregnancy and Choline Intake Alter the Metabolic Use of Orally Consumed Choline in Women Consuming Deuterium Labeled Choline

Maternal Choline Intake Modulates Maternal and Fetal Biomarkers of Choline Metabolism in Humans

Maternal Choline Supplementation Modulates Placental Nutrient Transport and Metabolism in Late Gestation of Mouse Pregnancy.

A Higher Maternal Choline Intake Favorably Alters Placental Gene Expression of Biological Pathways Related to Disease Risk

Choline Intakes Exceeding Recommendations During Human Lactation Improve Breast Milk Choline Content by Increasing PEMT Pathway Metabolites

Pregnancy Status and Choline Intake Alter DNA Integrity, Epigenetic Marks and Gene Expression

Characterization of Circulating Phosphatidylcholine Fatty Acids in Non‐pregnant Women with Supplemental DHA and Variable Choline Intake

Choline Affects Placental Vascular Function and Development in a Dose Response Manner

Maternal Choline Supplementation During Normal Murine Pregnancy Alters the Placental Epigenome: Results of an Exploratory Study.

Mechanisms of hepatic phosphatidylcholine synthesis in adult rat: effects of pregnancy

Maternal Choline Supplementation Alters Vitamin B-12 Status in Human and Murine Pregnancy

Maternal Choline Supplementation Modulates Maternal and Fetal Choline Metabolism and Downregulates Inflammatory Gene Expression in a Mouse Model of Placental Insufficiency

A Genome‐Wide Analysis of Placental Epigenetic Markers in Response to Maternal Choline Supplementation

A Higher Maternal Choline Intake among Third‐trimester Pregnant Women Lowers Placental and Circulating Concentrations of the Antiangiogenic Factor Fms‐like Tyrosine Kinase‐1 (Sflt1)

Choline and Betaine Alter Fetal Brain Expression of Genes Related to Docosahexaenoic Acid Availability in A Mouse Model of Gestational Diabetes

Maternal Choline Supplementation Influences Placental Glucose Uptake and Metabolism in a Manner Dependent on Fetal Sex

Fetal Stress Markers Are Lowered by Maternal Choline Intakes Exceeding Recommendations

Evidence of multiple hepatic mechanisms to mobilize docosahexaenoic acid into dam plasma during pregnancy in chow-fed sprague dawley rats